| answer text |
<p>Departmental officials have communicated with a range of manufacturers and importers
regarding the establishment of supplies of cannabis-based products for medicinal use
in the United Kingdom.</p><p> </p><p>Whilst the Secretary of State for Health and
Social Care has not met with Bedrocan, Tilray, GW Pharmaceuticals or Aphria, the former
Parliamentary Under Secretary of State (Lord O’Shaughnessy) did meet with GW Pharmaceuticals
once.</p><p> </p><p>Since January 2018, officials from the Department have met with
Bedrocan once, Tilray three times and GW Pharmaceuticals seven times (including a
meeting which involved the Department’s Chief Scientific Advisor). No meetings have
taken place between Departmental officials and Aphria.</p>
|
 |
